NS
IONS icon

NBC Securities’s Ionis Pharmaceuticals IONS Stock Holding History

NBC Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Hold
273
– – ﹤0.01% 1619
2026
Q1 		$20.5K Hold
273
– – ﹤0.01% 1699
2025
Q4 		$21.6K Hold
273
– – ﹤0.01% 1743
2025
Q3 		$17.9K Buy
+273
New +$13.3K ﹤0.01% 1798

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

NBC Securities's IONS Position: Q2 2026 in Review

NBC Securities held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 273 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

NBC Securities first reported a position in IONS in Q3 2025 and has held it in 4 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • NBC Securities held 273 shares of Ionis Pharmaceuticals worth $21.6K as of Q2 2026.
  • NBC Securities left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1619 holding.
  • NBC Securities first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.